Published in Dis Colon Rectum on August 01, 1998
Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg (2005) 4.86
Revised TN categorization for colon cancer based on national survival outcomes data. J Clin Oncol (2009) 4.09
MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins? Br J Cancer (2006) 1.68
Prognostic significance of depth of gross or microscopic perirectal fat invasion in T3 N0 M0 rectal cancers following sharp mesorectal excision and no adjuvant therapy. Int J Colorectal Dis (2003) 1.59
Extent of mesorectal tumor invasion as a prognostic factor after curative surgery for T3 rectal cancer patients. Ann Surg (2006) 1.24
Effectiveness of preoperative staging in rectal cancer: digital rectal examination, endoluminal ultrasound or magnetic resonance imaging? Br J Cancer (2004) 1.17
MRI in T staging of rectal cancer: How effective is it? Indian J Radiol Imaging (2010) 1.16
Prognostic determinants of patients with lateral nodal involvement by rectal cancer. Ann Surg (2001) 1.11
A prospective pathologic analysis using whole-mount sections of rectal cancer following preoperative combined modality therapy: implications for sphincter preservation. Ann Surg (2007) 1.02
What is the significance of the circumferential margin in locally advanced rectal cancer after neoadjuvant chemoradiotherapy? Ann Surg Oncol (2013) 0.99
Patterns of neoplastic foci and lymph node micrometastasis within the mesorectum. Langenbecks Arch Surg (2005) 0.90
Local excision carcinoma in early stage. World J Gastroenterol (2003) 0.85
Multimodal imaging evaluation in staging of rectal cancer. World J Gastroenterol (2014) 0.85
Preoperative downstaging chemoradiation with concurrent irinotecan and capecitabine in MRI-defined locally advanced rectal cancer: a phase I trial (NWCOG-2). Br J Cancer (2009) 0.85
Multidisciplinary teams in the management of rectal cancer. Clin Colon Rectal Surg (2007) 0.84
The importance of rectal cancer MRI protocols on interpretation accuracy. World J Surg Oncol (2008) 0.83
Rectal cancer staging: focus on the prognostic significance of the findings described by high-resolution magnetic resonance imaging. Cancer Imaging (2013) 0.82
Risk factors for local recurrence of middle and lower rectal carcinoma after curative resection. World J Gastroenterol (2008) 0.81
Circumferential resection margin involvement in stage III rectal cancer patients treated with curative resection followed by chemoradiotherapy: a surrogate marker for local recurrence? Yonsei Med J (2013) 0.81
Distal dissection in total mesorectal excision, and preoperative chemoradiotherapy and lateral lymph node dissection for rectal cancer. Surg Today (2013) 0.81
Results of treatment of distal rectal carcinoma since the introduction of total mesorectal excision: a single unit experience, 1994-2003. Int J Colorectal Dis (2004) 0.81
Occurrence and prognostic value of circumferential resection margin involvement for patients with rectal cancer. Int J Colorectal Dis (2009) 0.80
Magnetic resonance imaging (MRI)-based indication for neoadjuvant treatment of rectal carcinoma and the surrogate endpoint CRM status. Int J Colorectal Dis (2008) 0.80
Management of stage II/III rectal cancer. J Gastrointest Oncol (2010) 0.79
Sphincter-sparing resection for rectal cancer. Clin Colon Rectal Surg (2007) 0.79
Using p53-immunostained large specimens to determine the distal intramural spread margin of rectal cancer. World J Gastroenterol (2006) 0.78
Total mesorectal excision for rectal cancer: the truth lies underneath. World J Surg (2004) 0.77
Prognostic inhomogeneity in pT3 rectal carcinomas: comment. Int J Colorectal Dis (2002) 0.76
Changing the Way We Manage Rectal Cancer-Standardizing TME from Open to Robotic (Including Laparoscopic). Clin Colon Rectal Surg (2015) 0.76
Low rectal cancer: Sphincter preserving techniques-selection of patients, techniques and outcomes. World J Gastrointest Oncol (2015) 0.75
The pathologist's role in rectal cancer patient assessments. Clin Colon Rectal Surg (2007) 0.75
MRI and its importance in rectal cancer. Cancer Imaging (2000) 0.75
Comparison of conventional and three-dimensional conformal CT planning techniques for preoperative chemoradiotherapy for locally advanced rectal cancer. Br J Radiol (2011) 0.75
Study of circumferential resection margin in patients with middle and lower rectal carcinoma. World J Gastroenterol (2007) 0.75
Rectal cancer: a review. Med J Islam Repub Iran (2015) 0.75
Consensus statement: the 16th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Saskatoon, Saskatchewan; September 5-6, 2014. Curr Oncol (2015) 0.75
Clinical and oncologic outcomes of totally robotic total mesorectal excision for rectal cancer: initial results in a center for minimally invasive surgery. Int J Colorectal Dis (2016) 0.75
Risk factors for circumferential R1 resection after neoadjuvant radiochemotherapy and laparoscopic total mesorectal excision: a study in 233 consecutive patients with mid or low rectal cancer. Int J Colorectal Dis (2014) 0.75
Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet (1986) 10.07
The Vienna classification of gastrointestinal epithelial neoplasia. Gut (2000) 9.39
A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology (1997) 7.72
Screening dyspepsia by serology to Helicobacter pylori. Lancet (1991) 6.13
Unacceptable variation in abdominoperineal excision rates for rectal cancer: time to intervene? Gut (2008) 5.86
Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet (1994) 5.86
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer (2001) 5.36
Open access gastroscopy: too much to swallow? BMJ (1990) 4.52
Gastric cancer: a curable disease in Britain. BMJ (1993) 4.24
Direct polymerase chain reaction test for detection of Helicobacter pylori in humans and animals. J Clin Microbiol (1991) 3.91
WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc Natl Acad Sci U S A (1998) 3.73
Gastric dysplasia: the Padova international classification. Am J Surg Pathol (2000) 3.66
Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer. Br J Surg (2010) 3.63
Tissue extraction of DNA and RNA and analysis by the polymerase chain reaction. J Clin Pathol (1990) 3.30
Flat and depressed colonic neoplasms: a prospective study of 1000 colonoscopies in the UK. Lancet (2000) 3.23
Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis. J Clin Pathol (1987) 3.21
Cost effectiveness of antenatal screening for cystic fibrosis. BMJ (1995) 3.05
Surgical management and outcomes of colorectal cancer liver metastases. Br J Surg (2010) 3.03
The use of vacuum-assisted closure of abdominal wounds: a word of caution. Colorectal Dis (2007) 2.99
Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative. J Clin Pathol (1997) 2.98
Long-term follow-up of the Medical Research Council CLASICC trial of conventional versus laparoscopically assisted resection in colorectal cancer. Br J Surg (2012) 2.93
KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program. Virchows Arch (2008) 2.78
Unlocking the archive--gene expression in paraffin-embedded tissue. J Pathol (2001) 2.76
Reflux gastritis: distinct histopathological entity? J Clin Pathol (1986) 2.73
Choice of management strategy for colorectal cancer based on a diagnostic immunohistochemical test for defective mismatch repair. Gut (1999) 2.68
Identification of Helicobacter pylori DNA in the mouths and stomachs of patients with gastritis using PCR. J Clin Pathol (1993) 2.60
Observer variation in the histological grading of rectal carcinoma. J Clin Pathol (1983) 2.59
Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis. Gut (1990) 2.58
Chronic gastritis--a pathogenetic approach. J Pathol (1988) 2.31
Histological identification of Helicobacter pylori: comparison of staining methods. J Clin Pathol (2000) 2.31
Effect of duodenal ulcer surgery and enterogastric reflux on Campylobacter pyloridis. Lancet (1986) 2.27
Multicentre experience with extralevator abdominoperineal excision for low rectal cancer. Br J Surg (2010) 2.23
Genetic abnormalities during transition from Helicobacter-pylori-associated gastritis to low-grade MALToma. Lancet (1995) 2.21
An analysis of the reliability of detection and diagnostic value of various pathological features in Crohn's disease and ulcerative colitis. Gut (1973) 2.21
The use of a proforma improves colorectal cancer pathology reporting. Ann R Coll Surg Engl (1999) 2.20
Reappraisal of the 5 centimetre rule of distal excision for carcinoma of the rectum: a study of distal intramural spread and of patients' survival. Br J Surg (1983) 2.17
Early gastric cancer: 46 cases treated in one surgical department. Gut (1992) 2.10
Colorectal tumour deposits in the mesorectum and pericolon; a critical review. Histopathology (2007) 2.01
One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group. Gut (1997) 2.00
Campylobacter-like organisms unusual in type A (pernicious anaemia) gastritis. Lancet (1984) 2.00
PCR identification of Helicobacter pylori in faeces from gastritis patients. Lancet (1993) 2.00
Campylobacter like organisms and reflux gastritis. J Clin Pathol (1986) 1.99
Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther (2002) 1.94
Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology. Br J Cancer (1993) 1.93
Microsatellite instability in colorectal cancer: improved assessment using fluorescent polymerase chain reaction. Gastroenterology (1995) 1.92
Flat adenomas in the United Kingdom: are treatable cancers being missed? Endoscopy (1998) 1.92
Bladder and sexual function following resection for rectal cancer in a randomized clinical trial of laparoscopic versus open technique. Br J Surg (2005) 1.89
Failure of colonoscopic surveillance in ulcerative colitis. Gut (1993) 1.82
A novel subgroup of exogenous avian leukosis virus in chickens. J Gen Virol (1991) 1.82
The prediction of local recurrence in rectal adenocarcinoma by histopathological examination. Int J Colorectal Dis (1988) 1.72
Ileal ecology after pouch-anal anastomosis or ileostomy. A study of mucosal morphology, fecal bacteriology, fecal volatile fatty acids, and their interrelationship. Gastroenterology (1989) 1.71
p53 in colorectal cancer: clinicopathological correlation and prognostic significance. Br J Cancer (1991) 1.70
MALToma-like lesions in the murine gastric mucosa after long-term infection with Helicobacter felis. A mouse model of Helicobacter pylori-induced gastric lymphoma. Am J Pathol (1995) 1.70
Prognostic significance of DNA aneuploidy and cell proliferation in rectal adenocarcinomas. J Pathol (1987) 1.70
The rationale behind complete mesocolic excision (CME) and a central vascular ligation for colon cancer in open and laparoscopic surgery : proceedings of a consensus conference. Int J Colorectal Dis (2014) 1.69
DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: a molecular study. Lancet (2002) 1.68
Gastric epithelium in the duodenum: its association with Helicobacter pylori and inflammation. J Clin Pathol (1990) 1.68
The Sydney System revisited: the Houston International Gastritis Workshop. Am J Gastroenterol (1995) 1.68
Levels of nitrite, nitrate, N-nitroso compounds, ascorbic acid and total bile acids in gastric juice of patients with and without precancerous conditions of the stomach. Carcinogenesis (1991) 1.64
Structure of the human MSH2 locus and analysis of two Muir-Torre kindreds for msh2 mutations. Genomics (1994) 1.63
Effects of Helicobacter pylori eradication on the natural history of lymphocytic gastritis. Gut (1999) 1.62
c-Ki-ras gene mutations in dysplasia and carcinomas complicating ulcerative colitis. Br J Cancer (1991) 1.61
Mast cells are closely apposed to nerves in the human gastrointestinal mucosa. Gastroenterology (1989) 1.61
Methylation and colorectal cancer. J Pathol (2001) 1.61
Factors influencing bowel function after ileal pouch-anal anastomosis. Br J Surg (1986) 1.60
Bile reflux and intestinal metaplasia in gastric mucosa. J Clin Pathol (1993) 1.60
Intra-anal collagen injection for the treatment of faecal incontinence. Br J Surg (2006) 1.58
Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy. Gut (1995) 1.58
Ascorbic acid in the human stomach. Gastroenterology (1989) 1.58
Structure of the human MLH1 locus and analysis of a large hereditary nonpolyposis colorectal carcinoma kindred for mlh1 mutations. Cancer Res (1995) 1.57
Silver-stained structures (AgNORs), their dependence on tissue fixation and absence of prognostic relevance in rectal adenocarcinoma. J Pathol (1989) 1.57
High grade dysplasia of the gastric mucosa: a marker for gastric carcinoma. Gut (1990) 1.56
Total mesorectal excision and local recurrence: a study of tumour spread in the mesorectum distal to rectal cancer. Br J Surg (1995) 1.54
Intron splice acceptor site sequence variation in the hereditary non-polyposis colorectal cancer gene hMSH2. Eur J Cancer (1994) 1.54
Experience with surgical implantation of catheters for continuous ambulatory peritoneal dialysis. Ann R Coll Surg Engl (1985) 1.54
Measurement of anal cushions in idiopathic faecal incontinence. Br J Surg (2009) 1.54
Frequency of allele loss of DCC, p53, RBI, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction. Br J Cancer (1994) 1.53
Preservation of the spleen improves survival after radical surgery for gastric cancer. Gut (1995) 1.52
Allelic drop-out and preferential amplification in single cells and human blastomeres: implications for preimplantation diagnosis of sex and cystic fibrosis. Hum Reprod (1995) 1.52
Chemokine mRNA expression in gastric mucosa is associated with Helicobacter pylori cagA positivity and severity of gastritis. J Clin Pathol (1998) 1.51
Early diagnosis and prevention of sporadic colorectal cancer. Endoscopy (2001) 1.51
EMR using dextrose solution versus sodium hyaluronate for colorectal Paris type I and 0-II lesions: a randomized endoscopist-blinded study. Endoscopy (2008) 1.50